Drugmakers are opting to delist in order to seek greater management flexibility amid dual pressures of short-term investor scrutiny and government-forced price cuts.
Buyout wave seen among Japan drugmakers after Hisamitsu deal
Published 5 days ago
Source: japantimes.co.jp
Categories
BUSINESS
Related Articles from japantimes.co.jp
34 minutes ago
Japan's farm minister visits plant factory developer
42 minutes ago
Nikkei 225 hits new record after reports of possible snap election in Japan
1 hour ago
Jerome Powell: The careful Fed chair standing firm against Trump
1 hour ago
Jerome Powell: The careful Fed chair standing firm against Trump
1 hour ago
U.S. attacked boat with aircraft that looked like a civilian plane
1 hour ago